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Abstract 
Africa has high disease burden and health system challenges but is making progress 
in recognising, accepting and adopting evidence-based health care (EBHC).  In this 
paper, we reflect on the developments of the past two decades and consider further 
steps that will help with the translation of reliable research results into the decision 
making process.  
There has been a rapid growth in various initiatives to promote EBHC in the African 
region. These include the conduct and reporting of primary and secondary research, 
research capacity development and supportive initiatives, access to information, and 
work with decision makers in getting research into clinical guidelines and health 
policies. Much however still needs to be done to improve the impact on health in the 
region. A multipronged approach consisting of regionally relevant well conducted 
research addressing priority health problems, increased uptake of research in 
healthcare policy and practice, dedicated capacity development initiatives to support 
the conduct as well as use of research, facilitated by wider collaboration and 
equitable partnerships will be important.  
Working together in mutually supporting partnerships is key to advancing both 
evidence informed healthcare practices and better health. 
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Relevance of evidence-based health care and policy in Africa 
The disease burden in countries of Africa remains high: with increases in chronic 
non-infectious diseases adding to the already existing large burden of infectious 
diseases, injuries, and maternal and child health conditions [1]. Government health 
care is poorly resourced in general, with poor health system infrastructure and 
limited human resources. In the public sector, global initiatives and funds from 
donors can put pressure on existing services by funding particular initiatives, such as 
targeted disease control programmes. These can distort national priorities and 
human resource allocations.  
The formal private sector though not well developed, is increasingly becoming so in 
both middle and low income African countries, while the public healthcare system is 
perceived to offer ‘poor services for the poor.’ Under these conditions individuals and 
communities increasingly turn to private health care (formal or informal) and self-
treatment. This may result in their exploitation by predatory companies making false 
claims about their products and services, particularly in environments where the 
levels of income and education are low and government regulations non-existent or 
not enforced. Having ready access to reliable healthcare information will help the 
public, clinicians and governments to make the right choices [2].  
Evidence-based clinical care, the integration of current best available research 
evidence with clinical expertise and patient values and preferences, is gaining 
momentum in the African region. Whilst initially arising from clinical medicine to 
guide clinical decisions, increasingly these decisions impact on national and global 
policies; and the methods of research synthesis are being applied to public health 
problems. In the context of this broadened agenda, evidence–based health care 
(EBHC) and policy is a better way of describing the current status of shifting from 
research into public health policy and clinical practice, and is the scope of this article. 
 
Important strides have been taken to get EBHC onto the agenda at regional, national 
and local levels in some countries of Africa. In this paper we reflect on the 
developments of the past two decades and, consider further steps required to ensure 
that the results of reliable research continue to inform decision-making on the 
continent. 
EBHC in Africa: the past 2 decades 
Globally there has been an explosion of efforts aimed at developing research 
synthesis methods, conducting systematic reviews and designing structured ways of 
getting evidence into healthcare policies. People in Africa have played a key role in 
this process, mainly through Cochrane. Since its inception in 1997, Cochrane South 
Africa has formed part of this global network. It has worked with various stakeholders 
inside and outside of Africa to raise awareness of the importance of EBHC. It has 
spearheaded the conduct and support of regionally relevant Cochrane Reviews. 
Data from Cochrane’s contact database in September 2014 show that the number of 
Cochrane contributors from the Cochrane South Africa reference region (comprising 
a total of 25 countries in Sub-Saharan Africa) has increased considerably, with the 
majority located in South Africa and Nigeria (Figure 1). Working with Cochrane 
Review Groups for HIV/AIDS and Infectious Diseases, Cochrane South Africa has 
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trained, mentored and supported a large number of African review authors.  An 
average of 44 full Cochrane Reviews and 26 protocols were published each year by 
authors from Africa during 2009-2013. These authors frequently act as change 
agents advocating the use of systematic reviews within their home institutions and 
countries [3]. On an international scale, they have challenged global policy e.g. on 
the use of directly observed treatment strategy for tuberculosis [4] and continue to 
contribute to clinical guideline development. In the recent WHO Malaria guidelines, 
more than three quarters of the 11 Cochrane Reviews informing guideline 
development were authored by Africans [5].      
Systematic reviews help to identify gaps in the research base. There has been an 
increase in research productivity in the African region since 1991 which has been 
shown to be associated with the number of epidemiology training programmes, 
especially at the masteral level [6], and national gross domestic product [7]. The 
conduct of randomised trials, specifically, is being strengthened through funding from 
the US National Institutes of Health (NIH), Wellcome Trust and the EDCTP among 
others; the development of research ethics committees; the Pan African Clinical 
Trials Registry which allows prospective registration of trials [8,9]; and dedicated 
capacity development initiatives primarily through Masters and PhD programmes. 
While the growth in research productivity is a welcome development it remains 
unclear to what extent research is being informed by findings from systematic 
reviews. Furthermore, there is still a huge discrepancy between research capacity in 
Africa compared to that of Europe and North America [10]. This links with various 
factors, such as the lack of sustained investment in research and research capacity 
building and a lack of alignment between national and regional priorities and 
available funding [11].   
The availability of research evidence is, of course, only one of the inputs into the 
complex process of healthcare decision-making [12].  Healthcare decisions made by 
policymakers, healthcare professionals, managers, researchers, media, professional 
associations, and the public-at-large are influenced by many factors including cost, 
feasibility, and availability of products and services [13]. The priority given to best 
evidence in decisions can be influenced by these, as well many other factors, 
particularly competing interests, whether commercial, academic or political [14].  
We have witnessed a positive change in attitudes towards the use of evidence in 
healthcare planning. For example, at the start of the 21st century, when high rates of 
mother to child transmission of HIV was an important health problem, a Cochrane 
Review was undertaken in response to a direct request from the South African 
Department of Health for evidence on the effects of antiretroviral drugs for its 
prevention. On presenting the evidence to key decision makers, the door was literally 
closed in the face of the researchers because the evidence did not speak to what the 
decision makers wanted to hear. This was an all too typical case of policy based 
evidence (finding evidence to confirm instead of inform policy decisions) winning 
over evidence based policy [15]. Today, with the caveat that one needs to be clear 
on what the phrase means, it is unusual to see any policy without the words 
‘evidence based’ in it.      
It must be kept in mind that for evidence informed policymaking to succeed, 
proactive engagement of researchers with policymakers and other decision makers 
is required. Here, initiatives such as the Effective Health Care Research Consortium 
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(EHCRC), an international consortium working closely with African partners, in 
Cameroon, Kenya, Nigeria and South Africa, can be identified as an example of a 
group which has had considerable impact [3]. Since 2006, this consortium has gone 
beyond conducting relevant high quality reviews which inform policy and practice. It 
uses an explicit theory of change where the production of systematic reviews or their 
derivative products are considered outputs. Outcomes of interest include these 
outputs being accessed and used on the short term by decision makers, or on the 
medium term, to inform new or amended policies or guidelines. Long-term outcomes 
comprise EHCRC evidence being used to influence major funding decisions by bi-
lateral or multi-lateral agencies and an increased number of evidence-informed 
decisions being made by intermediary organisations and networks (e.g. WHO, 
bilateral) and national decision makers. Further examples of dedicated initiatives to 
promote evidence use in policymaking include the SUPPORT Collaboration which 
developed tools for policymakers [16]; the SURE Collaboration [17] which engages 
decision makers through deliberate dialogues to develop evidence-informed policy 
briefs, and by preparing rapid responses to policymakers in need of research 
evidence; and Evidence Aid which is seeking to improve access to systematic 
reviews relevant to disasters and other humanitarian emergencies, such as the ebola 
outbreak in West Africa in 2014 [18].   
There have also been promising developments in clinical guideline development and 
evaluation in the African region [13,19,20]. For example, Kredo and co-authors [19], 
assessed 30 regional guidelines from 13 countries linked to five priority diseases and 
found quality gaps in relation to the AGREE II tool and variable concordance with 
current best evidence. In this series the assessment by Machingaidze and co-
authors of South African primary healthcare guidelines had similar findings [21] 
illustrating the need for dedicated initiatives to advance and promote guideline 
development, reporting and implementation. Sinclair and co-authors [13], have 
similarly described a project in which researchers worked with the Ghana National 
Drugs Programme to review the evidence base for five priority areas in paediatric 
medicine. They considered both the international evidence base and the local 
applicability of the evidence and presented these as structured summaries to be 
used by guideline development teams.  
 
Indeed the Paediatric Association of Kenya is using explicit, transparent guideline 
development procedures. They made clear recommendations about stopping bolus 
fluids in shocky children based on the totality of the evidence (including the large 
FEAST trial in Africa evaluating this) [22], recommendations that the World Health 
Organization (WHO) has not yet implemented. This has benefited children by 
improving clinical care, reducing bolus treatments and saving lives, and shown that 
an African country appraise and apply evidence ahead of any guidelines from WHO. 
It is clear that existing international evidence-informed clinical guidelines are not 
always taken into account by African guideline development groups. This may be 
due to the peculiarities of local health systems, such as specific clinical care 
pathways and resource limitations; knowledge of evidence, and a reliance on clinical 
experience. To accelerate the availability and implementation of high quality local 
guidelines, a shift from new guideline development to guideline adaptation [23], 
application and evaluation would be helpful.  
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There has been recent growing recognition of the need for EBHC as demonstrated 
by multiple initiatives to promote the use of evidence in policymaking and practice 
(Table 1), the increased number of systematic reviews being commissioned and 
funded, and an increase in institutional initiatives to support the conduct of research. 
There has also been improved access to evidence through the HINARI initiative [24], 
and free one-click access to the Cochrane Library for people in many African 
countries. Furthermore, postgraduate and continuing professional development 
courses in EBHC are increasing whether measured in the number of programmes or 
the number of enrollees [25,26]. In 2012, the signing of the Kigali declaration on 
EBHC [27] by representatives from academe, hospitals, NGOs and research 
institutions from nine African countries, forming part of the Collaboration for Evidence 
based Health in Africa, signalled a key milestone in the recognition of EBHC and the 
momentum for moving towards the implementation of evidence based practices 
(Box).  
Future role of EBHC in Africa 
How can we ensure that all these developments in EBHC have the greatest impact 
on improving the lives of Africans? A multipronged approach consisting of regionally 
relevant and robust research addressing priority health problems, increased uptake 
of research in healthcare policy and practice, dedicated capacity development 
initiatives to support the conduct as well as use of research, facilitated by wider 
collaboration will be important. Avoiding research waste and unnecessary duplication 
will help ensure that initiatives remain sustainable.   
 
Conducting regionally relevant robust new research 
New research needs to be informed by the existing body of research [28,29] and 
such primary studies and systematic reviews must seek to answer relevant research 
questions [30]. They should not be driven solely by the agendas of funders or 
researchers. In striving for global excellence and local relevance, African 
researchers need to stay abreast of methodological developments and remain 
cognisant of research integrity principles. In this series Rohwer and co-authors [31] 
describe the application of logic model templates for systematic reviews and health 
technology assessments (HTA) of complex interventions. Various postgraduate 
programmes play a significant role in building relevant capacity [6]. However, these 
will need to be complemented by efforts to improve science literacy in schools, 
broad-based initiatives to empower a critical mass of local researchers to conduct 
and deliver internationally competitive research, support senior researchers to 
become role models and leaders, create enabling institutional environments for 
research, and build closer relationships between researchers on the one hand and 
health decision makers, funders and the public on the other [11].  
 
Dedicated specialised institutional and regional initiatives (centres of excellence) can 
also make an important contribution. For example, regional biostatisticians are 
joining together to strengthen capacity in biostatistics in Sub-Saharan Africa by 
increasing the number, and standards of, postgraduate programmes in biostatistics 
[32,33] in order to facilitate collaborative research initiatives and build biostatistics 
literacy. This aligns with the INCLEN, the International Clinical Epidemiology 
Network, which includes seven regional networks. Through the development of 
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Clinical Epidemiology Units, INCLEN has strengthened research capacity of medical 
schools in the African region [34]. Clinical epidemiologists, as key champions, link 
with biostatisticians and other researchers to foster research conduct and 
dissemination.   
 
Promoting the use of research to inform policy and practice  
The availability of robust research evidence on its own is not enough to impact on 
health care [34,35,36]. Sensitisation of undergraduates – the next generation of 
healthcare practitioners, healthcare managers, policy makers, and researchers – to 
the importance of research in decision making is important. Internationally, there is 
recognition and acceptance of the need to include teaching and learning of EBHC in 
the training of all healthcare professionals [37,38]. Despite this recognition, there is a 
still a general lack of coordinated country and regional efforts to support integration 
of EBHC at both undergraduate and postgraduate levels. Evidence informed 
strategies should be used to direct how EBHC learning can be mainstreamed into 
health professions education [39]. As part of the momentum towards transformative 
health professions education [40], the process of curriculum review presents useful 
opportunities to include and enhance EBHC learning. For instance, the Committee 
for Undergraduate Education and Training of the Health Professions Council of 
South Africa has adopted a modified version of the CanMEDS framework for 
establishing graduate attributes of a newly qualified healthcare professional [41]. It 
provides a guide to the essential competencies health professionals must have to 
optimise patient outcomes. The framework defines the attributes of the graduate 
according to seven interdependent roles: Medical Expert, Scholar (which includes 
most of the aspects of EBHC), Professional, Communicator, Collaborator, Manager 
and Health Advocate.  
Undergraduate training programmes in South Africa are being reviewed to better 
reflect these attributes. This period of change to the curriculum provides a window of 
opportunity to introduce, strengthen and integrate multifaceted EBHC teaching and 
learning with assessment [39, 42]. The process starts by assessing the current 
curriculum [43,44], and moves on to working with lecturers and programme 
convenors to plan pre-clinical and clinical EBHC learning, getting institutional buy in, 
and enhancing the competencies of the trainers to facilitate learning and, most 
importantly, acting as role models [45,46].  In the course of these activities, 
academic institutions can benefit through sharing best practices and using robust 
evaluations alongside implementation.  
Researchers also need to understand how the policy process and health system 
work, and engage with policy-makers to understand their priorities and information 
needs. This will guide efforts to access and interpret existing research, especially 
systematic reviews, conduct new research (where necessary) and complete and 
communicate research timeously and in appropriately tailored formats [47], in order 
to inform decision making at both policy development and implementation level. 
Clinical guideline development can be enhanced by following standardised 
approaches, followed by dedicated initiatives to support guideline implementation 
and evaluation. National and regional initiatives in this regard are in the pipeline. The 
recently launched G-I-N Africa [48] describes itself as ‘a regional community of 
clinical practice guideline developers, users and other stakeholders from the African 
continent who are interested in improving the effectiveness, rigor and efficiency of 
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guideline development, adaptation, dissemination, implementation and performance 
measurement.’ Initiatives such as these, need support and engagement from 
guideline development teams and ministries of health to avoid unnecessary 
duplication and ensure sustainability and impact. 
Partnership and collaboration are key guiding principles  
Collaboration between researchers and decision makers, between academic 
institutions, between academic and research institutions, and between cadres of 
specialist staff, is key to moving towards the common goal of evidence informed 
healthcare practices in the African region. By sharing best practices, collaborating 
and partnering on research and capacity development initiatives, avoiding 
unnecessary duplication and building equitable [49] long term relationships, African 
efforts to promote EBHC will go further [34,50,51].    
 
Conclusion 
There has been a rapid growth in various initiatives to promote EBHC in the African 
region. Much still needs to be done to improve impact on health in the region. 
Working together in mutually supporting partnerships is key to advancing both 
evidence informed healthcare practices and better health.   
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Table 1. Examples of EBHC initiatives in Africa – rapid growth in initiatives to promote 
EBHC  
Initiative Short description Website  
Alliance for Health 
Policy and Systematic 
reviews (AHPSR) 
An international collaboration hosted by the World Health 
Organization which goal is to promote the generation and 
use of health policy and systems research as a means to 
improve the health systems of LMIC  
http://www.who.int/allian
ce-hpsr/  
Collaboration for 
Evidence Based 
Healthcare in Africa 
(CEBHA)  
A network of institutions in Africa engaging in promoting 
EBHC in Africa. 
http://www.cebha.org/  
Development Research 
Uptake in Sub-Saharan 
Africa (DRUSSA) 
Provides direct support to universities at individual, 
institutional and systems levels to improve participation in 
and impact on policy and practice. 
http://www.drussa.net/  
Effective Health Care 
Research Consortium  
(EHCRC) 
 International consortium focusing on preparing and 
updating Cochrane Reviews about the effects of health 
care relevant to LMIC; and identifying approaches to 
ensure dissemination and use of the results of systematic 
reviews in decision making. 
http://www.evidence4he
alth.org/  
Evidence-Informed 
Policy Network 
(EVIPNet) 
Promotes the systematic use of health research evidence 
in policy-making focusing on LMIC, partnerships at the 
country level between policy-makers, researchers and civil 
society in order to facilitate both policy development and 
policy implementation through the use of the best 
scientific evidence available.  
http://global.evipnet.org/  
Knowledge translation 
Network (KNET) 
A network of eight research coalitions with membership of 
a coalition of researchers from 9 countries with the overall 
aim to promote and support the uptake and use of 
research evidence generated by their coalition partners 
who are funded by the Global Health Policy and Health 
Systems research programme.  
http://www.ktnetafrica.ne
t/  
Policy BUDDIES - 
BUilding Demand for 
evidence in Decision 
making 
through  Interaction and 
Enhancing Skills 
A collaborative project promoting researcher and 
policymaker engagement to promote evidence informed 
policymaking. 
http://www.cebhc.co.za/
policy-buddies/ 
South African Guideline 
Excellence (SAGE) 
project 
A collaborative project aiming to, through engaging in a 
stakeholder-driven process, improve the standards of 
local clinical guideline development, adaptation, 
contextualisation and, ultimately, implementation. 
http://www.mrc.ac.za/co
chrane/sage.htm  
SUPPORT An international Collaboration Network that involves a 
partnership between LMIC and European scientists and 
LMIC policymakers to provide training and support to 
encourage researchers and policymakers in collaborative 
policy-relevant research.  
http://www.support-
collaboration.org/  
Supporting the Use of 
Research Evidence 
(SURE) 
A collaborative project that builds on and supports 
EVIPNet in Africa and the Region of East Africa 
Community Health (REACH) Policy Initiative.  
http://www.who.int/evide
nce/sure/en/  
Global Evidence 
Synthesis Initiative 
(GESI) 
Brings together a number of worldwide research 
organisations that are committed to the development and 
use of research synthesis to enhance public policy, public 
service delivery and citizens’ involvement 
https://community.cochr
ane.org/sites/default/file
s/uploads/GESI%20-
%20Case%20for%20Su
pport%20-
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%20March%202015.pdf  
 
Legend: LMIC – Low- and Middle income countries 
Box: Recommendations from the Kigali declaration [27] 
- A sustainable collaboration to foster evidence based healthcare in Africa is developed  
- Health workers, policy makers and researchers are trained and infrastructure is             provid
ed to support evidence based healthcare  
- Evidence based healthcare is integrated into health education curricula   
- All health workers  have access to relevant electronic health information resources  
- Systematic reviews and guidelines relevant to African healthcare needs and disease     burde
n are developed   
- Health care practitioners, policy makers and consumers of health care are supported to 
identify and use reliable evidence in making healthcare decisions     
- Effective dissemination and implementation strategies are established  
- Research to further strengthen the knowledge base for the implementation of evidence based
 healthcare in the African context is encouraged and supported  
- Centres and satellite offices for evidence based healthcare are established in countries.  
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Figure 1: The growth in the number of Cochrane authors in Cochrane South Africa 
reference region* (2001-2014)  
 
 
 
*Reference region: Benin, Botswana, Cameroon, Comoros, Eritrea, Ethiopia, Gambia, Ghana, Kenya, 
Lesotho, Liberia, Madagascar, Malawi, Mauritius, Mozambique, Namibia, Nigeria, Sierra Leone, Somalia, 
South Africa, Swaziland, Tanzania, Uganda, Zambia and Zimbabwe. 
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